<DOC>
	<DOCNO>NCT02288182</DOCNO>
	<brief_summary>A randomize controlled clinical trial investigate capability Straumann® VivOss™ compare Geistlich Bio-Oss sinus floor augmentation demonstrate superiority Straumann® VivOss™ compare Geistlich Bio-Oss regard ratio newly form bone residual bone substitute .</brief_summary>
	<brief_title>Randomized , Controlled Study Compare Straumann® VivOss™ Geistlich Bio-Oss® Sinus Floor Augmentation .</brief_title>
	<detailed_description>This prospective , randomize , control study . The total study duration patient 9-14 month ( screen last visit ) . Enrolled subject randomize one follow group : 1 . Sinus floor elevation Straumann® VivOss™ 2 . Sinus floor elevation Geistlich Bio-Oss® In total 6 visit per patient schedule study . The histological evaluation ratio newly form bone residual bone graft , survival success rate study implant adverse event ( AEs ) assess . The study device Straumann® VivOss™ Geistlich Bio-Oss CE- ( Conformité Européenne , mean European Conformity ) mark product . Two center , one Germany one Switzerland participate .</detailed_description>
	<criteria>Subject must voluntarily sign inform consent study relate action Males females least 18 year age ( include 18 year ) Subject need augmentation procedure sinus prepare implant placement . Subject must residual bone height 2 4 mm . Adequate oral hygiene ( ( Full mouth plaque index ( O'Leary , et al . 1972 ) &lt; 25 % ) baseline Adequate control inflammation ( ( full mouth bleed probe ( Ainamo Bay 1975 ) ) ≤25 % baseline Systemic disease would interfere bone wound heal dental implant therapy ( e.g . uncontrolled diabetes ) Systemic disease would interfere bone wound heal dental implant therapy ( e.g . uncontrolled diabetes ) Any contraindication general bone graft oral surgical procedure Any anomaly sinus could interfere plan procedure History local irradiation therapy Local inflammation , include untreated periodontitis Medical condition require chronic high dose steroid therapy Treatment investigational drug device within 30 day period immediately prior surgery visit 2 , expect participation investigational drug device study conduct trial . Antibiotic treatment antiinflammatory treatment within 4 week prior surgery History alcoholism drug abuse Immunocompromised subject Subjects smoke &gt; 10 cigarette per day tobacco equivalent chew tobacco Conditions circumstance , opinion investigator , would prevent completion study participation interfere analysis study result , history noncompliance unreliability Physical mental disability would interfere ability perform adequate oral hygiene Current pregnancy ( pregnancy test ) breastfeed woman Secondary exclusion criterium : Defects Schneider Membrane</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Sinus augmentation procedure</keyword>
</DOC>